{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:28:16Z","timestamp":1791487696025,"version":"4.3.4"},"reference-count":70,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>The evaluation of the clustering of magnetic resonance imaging (MRI) signs into MRI types and their relationship with circulating markers of vascular wall damage were performed in 96 patients with cerebral small vessel disease (cSVD) (31 men and 65 women; mean age, 60.91 \u00b1 6.57 years). The serum concentrations of the tumor necrosis factor-\u03b1 (TNF-\u03b1), transforming growth factor-\u03b21 (TGF-\u03b21), vascular endothelial growth factor-A (VEGF-A), and hypoxia-inducible factor 1-\u03b1 (HIF-1\u03b1) were investigated in 70 patients with Fazekas stages 2 and 3 of white matter hyperintensities (WMH) and 21 age- and sex-matched volunteers with normal brain MRI using ELISA. The cluster analysis excluded two patients from the further analysis due to restrictions in their scanning protocol. MRI signs of 94 patients were distributed into two clusters. In the first group there were 18 patients with Fazekas 3 stage WMH. The second group consisted of 76 patients with WMH of different stages. The uneven distribution of patients between clusters limited the subsequent steps of statistical analysis; therefore, a cluster comparison was performed in patients with Fazekas stage 3 WMH, designated as MRI type 1 and type 2 of Fazekas 3 stage. There were no differences in age, sex, degree of hypertension, or other risk factors. MRI type 1 had significantly more widespread WMH, lacunes in many areas, microbleeds, atrophy, severe cognitive and gait impairments, and was associated with downregulation of VEGF-A compared with MRI type 2. MRI type 2 had more severe deep WMH, lacunes in the white matter, no microbleeds or atrophy, and less severe clinical manifestations and was associated with upregulation of TNF-\u03b1 compared with MRI type 1. The established differences reflect the pathogenetic heterogeneity of cSVD and explain the variations in the clinical manifestations observed in Fazekas stage 3 of this disease.<\/jats:p>","DOI":"10.3390\/diagnostics10060354","type":"journal-article","created":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T11:49:21Z","timestamp":1591012161000},"page":"354","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["MRI Types of Cerebral Small Vessel Disease and Circulating Markers of Vascular Wall Damage"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9929-2725","authenticated-orcid":false,"given":"Larisa A.","family":"Dobrynina","sequence":"first","affiliation":[{"name":"Research Center of Neurology, 80 Volokolamskoe shosse, 125367 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2523-333X","authenticated-orcid":false,"given":"Maryam R.","family":"Zabitova","sequence":"additional","affiliation":[{"name":"Research Center of Neurology, 80 Volokolamskoe shosse, 125367 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla A.","family":"Shabalina","sequence":"additional","affiliation":[{"name":"Research Center of Neurology, 80 Volokolamskoe shosse, 125367 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9396-6063","authenticated-orcid":false,"given":"Elena I.","family":"Kremneva","sequence":"additional","affiliation":[{"name":"Research Center of Neurology, 80 Volokolamskoe shosse, 125367 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulat M.","family":"Akhmetzyanov","sequence":"additional","affiliation":[{"name":"LLC PET-Technology, 58, korpus 2, ulica Zorge, 450054 Ufa, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7498-4063","authenticated-orcid":false,"given":"Zukhra Sh.","family":"Gadzhieva","sequence":"additional","affiliation":[{"name":"Research Center of Neurology, 80 Volokolamskoe shosse, 125367 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5387-4367","authenticated-orcid":false,"given":"Alexander B.","family":"Berdalin","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Institution \u201cFederal Center for Cerebrovascular Pathology and Stroke\u201d, 1, stroenie 10, Ostrovityanova, 117342 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila A.","family":"Kalashnikova","sequence":"additional","affiliation":[{"name":"Research Center of Neurology, 80 Volokolamskoe shosse, 125367 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6026-3388","authenticated-orcid":false,"given":"Elena V.","family":"Gnedovskaya","sequence":"additional","affiliation":[{"name":"Research Center of Neurology, 80 Volokolamskoe shosse, 125367 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina V.","family":"Krotenkova","sequence":"additional","affiliation":[{"name":"Research Center of Neurology, 80 Volokolamskoe shosse, 125367 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,5,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Pantoni, L., and Gorelick, P.B. (2014). Cerebral Small Vessel Disease, Cambridge University Press.","DOI":"10.1017\/CBO9781139382694"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1212\/WNL.0b013e31824e8e7f","article-title":"Staging and natural history of cerebrovascular pathology in dementia","volume":"78","author":"Deramecourt","year":"2012","journal-title":"Neurology"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"The LADIS Study Group, Poggesi, A., Pantoni, L., Inzitari, D., Fazekas, F., Ferro, J., O\u2019Brien, J., Hennerici, M., Scheltens, P., and Erkinjuntti, T. (2011). 2001\u20132011: A Decade of the LADIS (Leukoaraiosis And DISability) study: What have we learned about white matter changes and small-vessel disease?. Cereb. Dis., 32, 577\u2013588.","DOI":"10.1159\/000334498"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/ggi.12665","article-title":"Impact of cerebral white matter changes on functionality in older adults: An overview of the LADIS study results and future directions","volume":"15","author":"Pantoni","year":"2015","journal-title":"Geriatr. Gerontol. Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"41637","DOI":"10.1038\/srep41637","article-title":"Impact of small vessel disease in the brain on gait and balance","volume":"7","author":"Pinter","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3233\/JAD-170943","article-title":"Total MRI small vessel disease burden correlates with cognitive performance, cortical atrophy, and network measures in a memory clinic population","volume":"63","author":"Banerjee","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1474-4422(13)70060-7","article-title":"Mechanisms of sporadic cerebral small vessel disease: Insights from neuroimaging","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1212\/WNL.0000000000000837","article-title":"Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden","volume":"83","author":"Staals","year":"2014","journal-title":"Neurology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.neurobiolaging.2015.06.024","article-title":"Total MRI load of cerebral small vessel disease and cognitive ability in older people","volume":"36","author":"Staals","year":"2015","journal-title":"Neurobiol. Aging."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.03.002","article-title":"cerebral white matter hypoperfusion increases with small-vessel disease burden. Data from the third international stroke trial","volume":"26","author":"Arba","year":"2017","journal-title":"J Stroke Cereb. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fnagi.2013.00072","article-title":"Accumulation of MRI markers of cerebral small vessel disease is associated with decreased cognitive function. A study in first-ever lacunar stroke and hypertensive patients","volume":"5","author":"Huijts","year":"2013","journal-title":"Front. Aging. Neurosci."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Lawrence, A.J., Brookes, R.L., Zeestraten, E.A., Barrick, T.R., Morris, R.G., and Markus, H.S. (2015). Pattern and rate of cognitive decline in cerebral small vessel disease: A prospective study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0135523"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00401-011-0851-x","article-title":"Heterogeneity in age-related white matter changes","volume":"122","author":"Schmidt","year":"2011","journal-title":"Acta Neuropathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/jnnp.2009.204685","article-title":"Heterogeneity of small vessel disease: A systematic review of MRI and histopathology correlations","volume":"82","author":"Gouw","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/jcbfm.2015.116","article-title":"Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: A review","volume":"36","author":"Poggesi","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/2396987318805905","article-title":"Small vessel disease and biomarkers of endothelial dysfunction after ischaemic stroke","volume":"4","author":"Arba","year":"2019","journal-title":"Eur. Stroke J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jalz.2016.06.004","article-title":"METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the joint programme for neurodegenerative disease research","volume":"12","author":"Dichgans","year":"2016","journal-title":"Alzheimers Dement."},{"key":"ref_19","first-page":"191","article-title":"Harmonizing brain magnetic resonance imaging methods for vascular contributions to neurodegeneration","volume":"11","author":"Smith","year":"2019","journal-title":"Alzheimers Dement."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11936-017-0555-1","article-title":"Advanced neuroimaging of cerebral small vessel disease","volume":"19","author":"Blair","year":"2017","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1212\/WNL.0000000000001279","article-title":"Inflammatory biomarkers, cerebral microbleeds, and small vessel disease: Framingham Heart Study","volume":"84","author":"Shoamanesh","year":"2015","journal-title":"Neurology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.17116\/jnevro201811812223","article-title":"Biomarkers and mechanisms of early vascular damage","volume":"118","author":"Dobrynina","year":"2018","journal-title":"Zh. Nevrol. Psikhiatr. Im. SS Korsakova"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3390\/brainsci9100266","article-title":"Tissue plasminogen activator and MRI signs of cerebral small vessel disease","volume":"9","author":"Dobrynina","year":"2019","journal-title":"Brain Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jalz.2016.09.006","article-title":"Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: Evidence from a cohort study","volume":"6","author":"Wardlaw","year":"2017","journal-title":"Alzheimers Dement."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/jnc.14218","article-title":"Binswanger\u2019s disease: Biomarkers in the inflammatory form of vascular cognitive impairment and dementia","volume":"5","author":"Rosenberg","year":"2018","journal-title":"J. Neurochem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9507","DOI":"10.1126\/scitranslmed.aam9507","article-title":"Reversal of endothelial dysfunction reduces white matter vulnerability in cerebral small vessel disease in rats","volume":"10","author":"Rajani","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"100916","DOI":"10.1016\/j.arr.2019.100916","article-title":"Inflammation and cerebral small vessel disease: A systematic review","volume":"53","author":"Low","year":"2019","journal-title":"Ageing Res Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/1742-2094-9-235","article-title":"Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke","volume":"9","author":"Cui","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1179\/1743132813Y.0000000256","article-title":"TGF-beta1 is associated with the progression of intracranial deep white matter lesions: A pilot study with 5 years of magnetic resonance imaging follow-up","volume":"36","author":"Kuriyama","year":"2014","journal-title":"Neurol. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1136\/heartjnl-2015-309155","article-title":"Circulating vascular endothelial growth factor and the risk of cardiovascular events","volume":"102","author":"Kaess","year":"2016","journal-title":"Heart"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/STROKEAHA.118.022613","article-title":"Circulating vascular growth factors and magnetic resonance imaging markers of small vessel disease and atrophy in middle-aged adults","volume":"49","author":"Raman","year":"2018","journal-title":"Stroke"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the national institute on aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the national institute on aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J. Hypertens."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment","volume":"4","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr Soc."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Publishing. [5th ed.]. DSM-5.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.biopsych.2008.03.024","article-title":"Classification of white matter lesions on magnetic resonance imaging in elderly persons","volume":"64","author":"Kim","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000117270","article-title":"Inter-and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts","volume":"36","author":"Pasquier","year":"1996","journal-title":"Eur. Neurol."},{"key":"ref_39","unstructured":"Duran, B.S., and Odell, P.L. (2013). Cluster Analysis: A Survey, Springer Science & Business Media."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/bjs.1800520104","article-title":"Circulations of the cerebral hemispheres","volume":"52","author":"Rowbotham","year":"1965","journal-title":"Br. J. Surg."},{"key":"ref_41","first-page":"123","article-title":"Anastomoses in the vascular bed of the human cerebrum","volume":"27","author":"Ravens","year":"1968","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cell.2007.06.054","article-title":"Autocrine VEGF signaling is required for vascular homeostasis","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2990.2010.01139.x","article-title":"Review: Cerebral microvascular pathology in ageing and neurodegeneration","volume":"37","author":"Brown","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Peach, C.J., Mignone, V.W., Arruda, M.A., Alcobia, D.C., Hill, S.J., Kilpatrick, L.E., and Woolard, J. (2018). Molecular pharmacology of VEGF-A isoforms: Binding and signalling at VEGFR2. Int J. Mol. Sci., 19.","DOI":"10.3390\/ijms19041264"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.11.021","article-title":"Increased VEGF and decreased SDF-1alpha in patients with silent brain infarction are associated with better prognosis after first-ever acute lacunar stroke","volume":"24","author":"Kwon","year":"2015","journal-title":"J. Stroke Cerebrovasc Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1161\/STROKEAHA.113.001447","article-title":"Serum brain-derived neurotrophic factor and vascular endothelial growth factor levels are associated with risk of stroke and vascular brain injury: Framingham study","volume":"44","author":"Pikula","year":"2013","journal-title":"Stroke"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrn1408","article-title":"HIF1 and oxygen sensing in the brain","volume":"5","author":"Sharp","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/mol.107.036418","article-title":"Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression","volume":"72","author":"Yeh","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.nbd.2016.07.012","article-title":"Role of hypoxia inducible factor 1 in hyperglycemia-exacerbated blood-brain barrier disruption in ischemic stroke","volume":"95","author":"Zhang","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1161\/01.STR.0000221308.94473.14","article-title":"White matter lesions in an unselected cohort of the elderly: Molecular pathology suggests origin from chronic hypoperfusion injury","volume":"37","author":"Fernando","year":"2006","journal-title":"Stroke"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1631\/jzus.2005.B1045","article-title":"Acute phase reaction and acute phase proteins","volume":"6","author":"Gruys","year":"2005","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J. Pathol."},{"key":"ref_53","first-page":"1","article-title":"TNF pathophysiology molecular and cellular mechanisms","volume":"11","author":"Kollias","year":"2010","journal-title":"Curr. Dir. Autoimmun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000289195","article-title":"Cellular mechanisms of TNF function in models of inflammation and autoimmunity","volume":"11","author":"Apostolaki","year":"2010","journal-title":"Curr. Dir. Autoimmun."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0168-0102(01)00195-X","article-title":"Oligodendroglial cell death with DNA fragmentation in the white matter under chronic cerebral hypoperfusion: Comparison between normotensive and spontaneously hypertensive rats","volume":"39","author":"Masumura","year":"2001","journal-title":"Neurosci. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1471-4159.2003.01829.x","article-title":"Secretion of interleukin-1beta by astrocytes mediates endothelin-1 and tumour necrosis factor-alpha effects on human brain microvascular endothelial cell permeability","volume":"86","author":"Didier","year":"2003","journal-title":"J. Neurochem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/jnr.22257","article-title":"Divergent role for MMP-2 in myelin breakdown and oligodendrocyte death following transient global ischemia","volume":"88","author":"Walker","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1742-2094-8-108","article-title":"Tissue inhibitor of metalloproteinases-3 mediates the death of immature oligodendrocytes via TNF-alpha\/TACE in focal cerebral ischemia in mice","volume":"8","author":"Yang","year":"2011","journal-title":"J. Neuroinflamm."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s13105-014-0366-8","article-title":"Tumor necrosis factor-alpha-induced microvascular endothelial cell hyperpermeability: Role of intrinsic apoptotic signaling","volume":"70","author":"Sawant","year":"2014","journal-title":"J. Physiol. Biochem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/exnr.2002.7871","article-title":"TNF alpha transport across the blood-brain barrier is abolished in receptor knockout mice","volume":"2","author":"Pan","year":"2002","journal-title":"Exp. Neurol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.neurobiolaging.2011.04.008","article-title":"Vascular inflammation in cerebral small vessel disease","volume":"33","author":"Rouhl","year":"2012","journal-title":"Neurobiol. Aging."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2174\/1567205013666160930110551","article-title":"Targeting tumor necrosis factor alpha for Alzheimer\u2019s disease","volume":"14","author":"Decourt","year":"2017","journal-title":"Curr. Alzheimer Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/jcbfm.2015.71","article-title":"Genetic factors in cerebral small vessel disease and their impact on stroke and dementia","volume":"36","author":"Haffner","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1161\/STROKEAHA.108.542266","article-title":"Living beyond our physiological means: Small vessel disease of the brain is an expression of a systemic failure in arteriolar function: A unifying hypothesis","volume":"40","author":"Thompson","year":"2009","journal-title":"Stroke"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0002-9440(10)64713-X","article-title":"Chronic overproduction of transforming growth factor-beta 1 by astrocytes promotes Alzheimer\u2019s disease-like microvascular degeneration in transgenic mice","volume":"156","author":"Lin","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/FJC.0000000000000177","article-title":"Cerebral circulation: Function and dysfunction in Alzheimer\u2019s disease","volume":"65","author":"Hamel","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Seo, J.H., Maki, T., Maeda, M., Miyamoto, N., Liang, A.C., Hayakawa, K., Pham, L.D., Suwa, F., Taguchi, A., and Matsuyama, T. (2014). Oligodendrocyte precursor cells support blood-brain barrier integrity via TGF-beta signaling. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0103174"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1113\/jphysiol.2010.194753","article-title":"Arterial stiffening with ageing is associated with transforming growth factor-beta1-related changes in adventitial collagen: Reversal by aerobic exercise","volume":"588","author":"Fleenor","year":"2010","journal-title":"J. Physiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-beta: The master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3389\/fphar.2017.00824","article-title":"Novel therapeutic targets and emerging treatments for fibrosis","volume":"8","author":"Samuel","year":"2017","journal-title":"Front. Pharmacol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/10\/6\/354\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:33:43Z","timestamp":1760175223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/10\/6\/354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,29]]},"references-count":70,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["diagnostics10060354"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics10060354","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,29]]}}}